Evli Maailma B vs UBS Lux Equity Fund Biotech USD

Evli Maailma B vs UBS Lux Equity Fund Biotech USD

1. Evli Maailma B

  • Security

    Evli Maailma B

  • Fee

    1.61%

  • ISIN

    FI0008801188

  • Holdings

    7

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 7 holdings in Evli Maailma B, where the largest holding is Betsson (2.7), followed by Allison Transmission (2.42) and Ahold Delhaize (2.3). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Evli Maailma B and UBS Lux Equity Fund Biotech USD.

Evli Maailma B UBS Lux Equity Fund Biotech USD
1. Betsson B
2.7 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Allison Transmission Holdings Inc
2.42 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Ahold Delhaize NV
Netherlands
2.3 %
3. Moderna Inc
9.21 %
4. Cencora Inc
USA
2.16 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Dropbox Inc
USA
2.12 %
5. AbbVie Inc
USA
5.53 %
6. Novartis AG
Switzerland
2.09 %
6. Gilead Sciences Inc
USA
4.66 %
7. Bunzl Plc
UK
1.87 %
7. Amgen Inc
4.3 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 6, 2025.